Albumin-free botulinum toxin formulations

Details for Australian Patent Application No. 2010265888 (hide)

Owner Revance Therapeutics, Inc.

Inventors Thompson, Stewart A.; Ruegg, Curtis L.; Waugh, Jacob M.

Agent Freehills

Pub. Number AU-A-2010265888

PCT Pub. Number WO2010/151840

Priority 61/220,433 25.06.09 US

Filing date 25 June 2010

Wipo publication date 29 December 2010

International Classifications

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A61K 8/99 (2006.01) Cosmetics or similar toilet preparations

A61P 21/02 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61Q 19/08 (2006.01) Preparations for care of the skin - Anti-ageing preparations

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/151840 Priority application(s): WO2010/151840

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010265889-Single nucleotide polymorphisms in BRCA1 and cancer risk

2010265883-Power distribution apparatus with input and output power sensing and method of use